Ashwin A. Kallianpur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ashwin A. Kallianpur has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Arvind Kapali
1 shared publicationDillip Mudaly
Department of surgical oncology, all india institute of medical science, New Delhi, India
1 shared publication- Majid Ahmed Talikoti
Department of Surgical Oncology, BRAIRCH, AIIMS, New Delhi, 110029, India
1 shared publication - Mamraj Gupta
Department of Surgical Oncology, BRAIRCH, AIIMS, New Delhi, 110029, India
1 shared publication Mandeep Singh
1 shared publicationNootan K Shukla
1 shared publication
Latest Publications
- Open Access
- 1 April 2012
- Published by Wolters Kluwer Health in Tropical Gastroenterology
- Vol. 33 (2) , 155-158
A rare case of gallbladder carcinoma metastases to the breast treated with curative intent
- 1 April 2012
- Published by Wolters Kluwer Health in Tropical Gastroenterology
- Vol. 33 (2) , 155-158
Open AccessA rare case of gallbladder carcinoma metastases to the breast treated with curative intent
- 3 January 2012
- Published by Wiley in Journal of Surgical Oncology
- Vol. 105 (6) , 617-621
Updates on the multimodality management of desmoplastic small round cell tumor
Desmoplastic Small Round Cell Tumor (DSRCT) is a rare and an aggressive malignancy with poor outcome. This tumor can co‐express epithelial, neural, and mesenchymal markers. The molecular hallmark of DSRCT is the EWS–WT1 fusion protein. Despite the diversities in treatment modality, the best results have been seen with radical surgery and adjuvant or neoadjuvant chemotherapy. J. Surg. Oncol. 2012; 105:617–621.
- 3 January 2012
- Published by Wiley in Journal of Surgical Oncology
- Vol. 105 (6) , 617-621
Updates on the multimodality management of desmoplastic small round cell tumor
Desmoplastic Small Round Cell Tumor (DSRCT) is a rare and an aggressive malignancy with poor outcome. This tumor can co‐express epithelial, neural, and mesenchymal markers. The molecular hallmark of DSRCT is the EWS–WT1 fusion protein. Despite the diversities in treatment modality, the best results have been seen with radical surgery and adjuvant or neoadjuvant chemotherapy. J. Surg. Oncol. 2012; 105:617–621.
- Open Access
- 10 February 2011
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 9 (1) , 20
A rare case of giant leiomyosarcoma in a filarial scrotum: a case report
Giant leiomyosarcoma of scrotum is a rare tumour. A case of scrotum leiomyosarcoma is presented in a 67 year old patient with scrotal filariasis which was managed successfully with total scrotectomy with bilateral orchidectomy, degloved penis reconstructed with rotation advancement supra pubic fasciocutaneous flap. We made a literature search proving the rarity of this lesion type. Only 36 cases have been described and the first case in a filarial scrotum
- 10 February 2011
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 9 (1) , 20
Open AccessA rare case of giant leiomyosarcoma in a filarial scrotum: a case report
Giant leiomyosarcoma of scrotum is a rare tumour. A case of scrotum leiomyosarcoma is presented in a 67 year old patient with scrotal filariasis which was managed successfully with total scrotectomy with bilateral orchidectomy, degloved penis reconstructed with rotation advancement supra pubic fasciocutaneous flap. We made a literature search proving the rarity of this lesion type. Only 36 cases have been described and the first case in a filarial scrotum